外染色体DNA驱动的瘤基因空间异质性和质母细胞瘤的演变
bioRxiv : the preprint server for biology
|November 1, 2024
概括
外染色体DNA (ecDNA) 放大驱动着质母细胞瘤的进化和治疗耐药性. 早期检测ecDNA,特别是EGFR变异,可能为干预提供治疗窗口.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 计算生物学 计算生物学
背景情况:
- 外染色体DNA (ecDNA) 放大是癌症的关键驱动因素,特别是质母细胞瘤,有助于治疗耐药性和低生存率.
- 对于ecDNA的空间动态和进化影响的了解仍然很少,这阻碍了有效的治疗策略.
研究的目的:
- 研究质母细胞瘤中的ecDNA的时空演变及其临床影响.
- 开发和应用一个计算模型来分析患者瘤样本中的ecDNA动态.
主要方法:
- 来自94名未接受过治疗的IDH野生型质母细胞瘤患者的瘤样本的分析.
- 开发了SPECIES计算模型,整合了全基因组测序,DNA FISH和RNA范围.
- 模拟ecDNA空间动态,拷贝数变化和选择压力.
主要成果:
- 确定了EGFR和PDGFRAecDNA的独特进化轨迹,EGFRecDNA的拷贝数量更高,阳性选择更强.
- 证明EGFR的ecDNA,包括像EGFRvIII这样的变体,通常在瘤发育的早期形成,在克隆扩张之前.
- 展示了SPECIES模型推断空间进化动态的能力,并根据ecDNA积累时间确定潜在的治疗窗口.
结论:
- ecDNA副本数变化的空间模式是可预测的,并受到特定瘤基因放大的影响.
- EGFR的ecDNAs,特别是变异,早期出现,并对质母细胞瘤瘤产生作出重大贡献.
- 早期发现ecDNA可能为质母细胞瘤的治疗干预提供一个关键的窗口.
更多相关视频
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K


